Schlagwörter
survival
6
CARE
4
CHEMOTHERAPY
4
GNA11
4
HEPATIC PERFUSION
4
IMPACT
4
IPILIMUMAB
4
MUTATIONS
4
OUTCOMES
4
PHASE-II
4
PROGNOSIS
4
SF3B1
4
advanced melanoma
4
metastatic uveal melanoma
4
prognostic factor
4
treatment strategy
4
uveal melanoma
4
COVID-19
2
Cancer Research
2
DABRAFENIB
2
METASTATIC MELANOMA
2
MULTICENTER
2
Oncology
2
POOLED ANALYSIS
2
VEMURAFENIB
2
center variation
2
clinical outcomes
2
nationwide registry
2
systemic therapy
2